Crowdly
Add to Chrome
PHY3171 - Cardiovascular physiology and disease - S1 2026
Looking for PHY3171 - Cardiovascular physiology and disease - S1 2026 test answers and solutions? Browse our comprehensive collection of verified answers for PHY3171 - Cardiovascular physiology and disease - S1 2026 at learning.monash.edu.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
Which of the following strategies can help reduce the risk of anthracycline-induced cardiotoxicity?
0%
0%
0%
0%
View this question
In women, the balance between angiotensin II (vasoconstrictor) and angiotensin-(1-7) (vasodilator) tends to shift toward:
❌
❌
❌
✅
View this question
Which of the following is a reason why women may have worse outcomes after cardiovascular disease diagnosis?
✅
❌
❌
❌
View this question
What is a key implication for healthcare providers based on the epidemiology of CVD in cancer survivors?
❌
✅
❌
❌
View this question
Cancer therapy-induced cardiotoxicity can result from which of the following?
❌
❌
❌
✅
View this question
Which of the following is a female-specific cardiovascular risk factor?
✅
❌
❌
❌
View this question
Menopause is associated with increased risk of which cardiovascular events?
❌
❌
✅
❌
View this question
Which biomarker is often measured to assess cardiac injury during chemotherapy?
❌
❌
❌
✅
View this question
How does the risk of long-term cardiac dysfunction differ between Type I and Type II cardiotoxicity?
❌
❌
❌
✅
View this question
Which of the following is a recognised challenge in advancing the field of reverse cardio-oncology?
❌
❌
✅
❌
View this question